Special Investigation Of Long Term Use Of Sertraline.

Viatris

Status: Completed

Conditions: Panic Disorder; Depression

Treatments: Drug: Sertraline hydrochloride

Study type: Observational

Funder types: Industry

Identifiers

NCT00605813

A0501091

Details and patient eligibility

About

Special investigation of long term use of sertraline, 52 Week Observation, Long-Term Safety. The objective of this "Special investigation" is to collect information about 1) adverse drug reactions not expected from the LPD (unknown adverse drug reactions), 2) the incidence of adverse drug reactions in this surveillance, and 3) factors considered to affect the safety and/or efficacy of this drug regarding long time use.

Full description

All the patients for whom an investigator prescribes the first sertraline hydrochloride should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Enrollment: 542 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

The patients who take sertraline hydrochloride for longer than the duration of 16 weeks among the patients enrolled in A0501090 (Drug Use Investigation of J Zoloft).

Exclusion criteria

Patients not taking sertraline hydrochloride.

Trial design

542 participants in 1 patient group

Sertraline hydrochloride.

Description:

Patients taking Sertraline hydrochloride.

Treatment:

Drug: Sertraline hydrochloride